PLASMINOGEN ACTIVATOR INHIBITOR-1 PAI-1 Test
At DNA Labs UAE, we offer the PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) test, which measures the levels of PAI-1 in the blood. PAI-1 is a protein that regulates the breakdown of blood clots by inhibiting the activity of plasminogen activators.
Test Details
The PAI-1 test is primarily used to evaluate the risk of developing blood clotting disorders, such as deep vein thrombosis (DVT) or pulmonary embolism (PE). It can also assess the risk of cardiovascular diseases, including heart attack and stroke.
High levels of PAI-1 in the blood are associated with an increased risk of blood clot formation, while low levels may indicate a decreased ability to form blood clots, which can increase the risk of excessive bleeding.
The PAI-1 test is typically ordered by a hematologist if a person has a personal or family history of blood clotting disorders or risk factors for cardiovascular diseases. It may also be ordered as part of a routine blood workup or to monitor the effectiveness of treatment for certain conditions.
Test Procedure
The PAI-1 test involves collecting a blood sample from a vein in the arm. The sample is then sent to our laboratory for analysis. Results are usually reported as a numerical value representing the concentration of PAI-1 in the blood.
It is important to note that the PAI-1 test is just one piece of the puzzle when assessing a person’s risk for blood clotting disorders or cardiovascular diseases. Other factors, such as family history, lifestyle, and additional blood tests, may also be taken into consideration.
Therefore, it is crucial to discuss the results of the PAI-1 test with a healthcare provider, specifically a hematologist, to fully understand their implications and any necessary follow-up actions.
Test Cost and Sample Requirements
The cost of the PLASMINOGEN ACTIVATOR INHIBITOR-1 PAI-1 test is AED 2410.0. To perform the test, a sample of 2 mL (minimum 1 mL) plasma from 1 Blue Top (Sodium Citrate) tube is required. The plasma should be separated and frozen immediately. It is important not to thaw the sample. Additionally, a duly filled Test Send Out Consent Form is mandatory.
Report Delivery
The sample for the PAI-1 test should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.
Conclusion
The PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) test offered by DNA Labs UAE is a valuable tool in assessing the risk of blood clotting disorders and cardiovascular diseases. It provides crucial information about the levels of PAI-1 in the blood, which plays a significant role in the regulation of blood clot breakdown. By discussing the test results with a healthcare provider, individuals can gain a better understanding of their risk factors and take appropriate actions to maintain their health.
Test Name | PLASMINOGEN ACTIVATOR INHIBITOR-1 PAI-1 Test |
---|---|
Components | |
Price | 2410.0 AED |
Sample Condition | 2 mL (1 mL min.) plasma from 1 Blue Top(SodiumCitrate)tube. Separate plasma & freeze immediately. Ship frozen. DO NOT THAW. Duly filled Test Send Out Consent Formis mandatory. |
Report Delivery | Sampleby7thofthemonth;Report after2??3weeks |
Method | EIA |
Test type | Thromboembolic disorders |
Doctor | Hematologist |
Test Department: | OS |
Pre Test Information | Duly filled Test Send Out Consent Formis mandatory. |
Test Details |
The Plasminogen Activator Inhibitor-1 (PAI-1) test is a blood test that measures the levels of PAI-1 in the blood. PAI-1 is a protein that plays a crucial role in regulating the breakdown of blood clots. It inhibits the activity of plasminogen activators, which are enzymes responsible for breaking down blood clots. The PAI-1 test is primarily used to evaluate the risk of developing blood clotting disorders, such as deep vein thrombosis (DVT) or pulmonary embolism (PE). It can also be used to assess the risk of cardiovascular diseases, including heart attack and stroke. High levels of PAI-1 in the blood are associated with an increased risk of blood clot formation, while low levels may indicate a decreased ability to form blood clots, which can increase the risk of excessive bleeding. The PAI-1 test is typically ordered by a healthcare provider if a person has a personal or family history of blood clotting disorders or if they have risk factors for cardiovascular diseases. It may also be ordered as part of a routine blood workup or to monitor the effectiveness of treatment for certain conditions. The test is performed by collecting a blood sample from a vein in the arm. The sample is then sent to a laboratory for analysis. Results are usually reported as a numerical value representing the concentration of PAI-1 in the blood. It is important to note that the PAI-1 test is just one piece of the puzzle when assessing a person’s risk for blood clotting disorders or cardiovascular diseases. Other factors, such as family history, lifestyle, and additional blood tests, may also be taken into consideration. Therefore, it is important to discuss the results of the PAI-1 test with a healthcare provider to fully understand their implications and any necessary follow-up actions. |